1. Home
  2. TIVC vs SPRC Comparison

TIVC vs SPRC Comparison

Compare TIVC & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tivic Health Systems Inc.

TIVC

Tivic Health Systems Inc.

HOLD

Current Price

$1.40

Market Cap

3.6M

Sector

Health Care

ML Signal

HOLD

Logo SciSparc Ltd.

SPRC

SciSparc Ltd.

HOLD

Current Price

$8.62

Market Cap

2.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TIVC
SPRC
Founded
2016
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6M
2.5M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
TIVC
SPRC
Price
$1.40
$8.62
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
86.9K
308.5K
Earning Date
05-14-2026
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$780,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.75
$0.27
52 Week High
$5.60
$9.03

Technical Indicators

Market Signals
Indicator
TIVC
SPRC
Relative Strength Index (RSI) 69.31 74.14
Support Level $0.79 $3.21
Resistance Level $2.70 $8.90
Average True Range (ATR) 0.11 1.06
MACD 0.03 0.40
Stochastic Oscillator 100.00 89.69

Price Performance

Historical Comparison
TIVC
SPRC

About TIVC Tivic Health Systems Inc.

Tivic Health Systems Inc is a late-stage biopharmaceutical company focused on the development of biologics, with its lead product candidate, Entolimod, a TLR5 agonist, being developed for acute radiation syndrome and oncology-related indications. The company operates through two segments: a biopharma segment focused on product development and commercialization, and a contract development and manufacturing organization (CDMO) segment providing manufacturing and development services through its subsidiary.

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Share on Social Networks: